Becton Dickinson and Company (BDX) Stock Forecast
US · Healthcare
Current price
$151.38
Market cap
$41.71B
Mean price target
$177.75
Implied upside
17.4%
Key takeaways
- Analysts rate Becton Dickinson and Company a “Buy”, with a mean price target of $177.75 — about 17.4% upside from the current $151.38, based on 12 analysts.
- BDX is trading in the middle of its 52-week range, at 40% of the $127.59–$187.35 band.
Analyst consensus
| Consensus rating | Buy |
|---|---|
| Number of analysts | 12 |
| Mean target | $177.75 |
| High target | $225.00 |
| Low target | $150.00 |
| Rating split (SB / B / H / S / SS) | 1 / 4 / 9 / 0 / 0 |
Price & trading
| Current price | $151.38 |
|---|---|
| Previous close | $147.77 |
| 52-week high | $187.35 |
| 52-week low | $127.59 |
| 50-day average | $148.31 |
| Beta | 0.28 |
See the full BDX breakdown on Luminoso
Valuation, profitability, efficiency, leverage & earnings-quality metrics — updated daily.
Start free — 2 months on usFrequently asked questions
- What is the current Becton Dickinson and Company (BDX) share price?
- Becton Dickinson and Company last traded at $151.38 with a market capitalisation of about $41.7B.
- What is the analyst price target for BDX?
- The mean analyst price target for Becton Dickinson and Company is $177.75, roughly 17.4% above the latest price. The current consensus rating is “Buy”.
- Where can I see Becton Dickinson and Company's full financial metrics?
- Luminoso tracks BDX's valuation, profitability, efficiency, leverage and earnings-quality metrics alongside analyst data — updated daily. Create a free account to explore the full breakdown.
More stocks
Browse all companies covered by Luminoso →
Last updated 25 Jun 2026.
Data is provided for informational purposes only and is not investment advice. Figures are cached and refreshed daily; they may differ from real-time quotes.